Prognostic significance of the advanced lung cancer inflammation index for long-term mortality in patients with acute myocardial infarction and diabetes - Scorecard - MDSpire

Prognostic significance of the advanced lung cancer inflammation index for long-term mortality in patients with acute myocardial infarction and diabetes

  • By

  • Hongqiang Li

  • Jiachen Luo

  • Gang Li

  • Fei Yang

  • Yidong Wei

  • July 6, 2026

  • 0 min

Share

Clinical Scorecard: Prognostic Value of the Advanced Lung Cancer Inflammation Index in Predicting Long-Term Mortality Among Diabetic Patients with Acute Myocardial Infarction

At a Glance

CategoryDetail
ConditionAcute Myocardial Infarction with Diabetes
Key MechanismsInflammation, Nutrition, Metabolism
Target PopulationDiabetic patients with acute myocardial infarction
Care SettingCardiac Care Unit

Key Highlights

  • Higher ALI tertile (T3) associated with 67% reduction in all-cause mortality risk.
  • Significant non-linear relationship between continuous ALI and mortality outcomes.
  • Lower ALI correlates with increased all-cause and cardiovascular mortality.

Guideline-Based Recommendations

Diagnosis

  • AMI diagnosed per Fourth Universal Definition of Myocardial Infarction.

Management

  • Consider ALI as a prognostic marker for risk stratification in diabetic AMI patients.

Monitoring & Follow-up

  • Monitor ALI levels for assessing long-term mortality risk.

Risks

  • Higher mortality risk associated with lower ALI levels.

Patient & Prescribing Data

571 diabetic AMI patients

ALI can enhance risk stratification and personalized management.

Clinical Best Practices

  • Utilize ALI for early risk assessment in diabetic AMI patients.
  • Incorporate ALI into existing risk models like the GRACE score.

Related Resources & Content

Original Source(s)

Prognostic significance of the advanced lung cancer inflammation index for long-term mortality in patients with acute myocardial infarction and diabetes

  • by Hongqiang Li, Jiachen Luo, Gang Li, Fei Yang, Yidong Wei

  • July 6, 2026

Related Content

Investigational Drug Shows Potentialin Phase 3 Obesity Trial

In a 76-week randomized trial, patients with obesity without diabetes who received survodutide achieved greater weight loss and favorable changes in several metabolic measures compared with those who received placebo.

How Quickly Are Patients Reaching Quadruple HFrEF Therapy?

Delays in initiating guideline-directed quadruple therapy may increase early clinical risk in heart failure with reduced ejection fraction.

Metabolic Health Tied to Dementia

In two population-based cohorts, metabolically unhealthy status generally showed higher dementia risk estimates, while metabolically healthy obesity was not associated with increased risk in primary analyses.